bims-supasi Biomed News
on Sulfation pathways and signalling
Issue of 2026–11–08
eleven papers selected by
Jonathan Wolf Mueller, University of Birmingham



  1. Eur J Med Chem. 2026 Oct 29. pii: S0223-5234(26)00919-0. [Epub ahead of print]321(Pt 3): 119474
      Fucosylated chondroitin sulfate is a structurally distinctive marine glycosaminoglycan whose biological functions are strongly influenced by sulfation. Here, we synthesized a 15-member fucosylated chondroitin sulfate oligosaccharide library and evaluated its protein-binding properties and the antifibrotic activity of a lead trisaccharide. Surface plasmon resonance analysis showed that N-acetylgalactosamine 4,6-O-desulfation enhanced Galectin-3 binding (KD value 0.255 μM). The lead trisaccharide also bound high mobility group box 1 (HMGB1) with a KD value of 0.214 μM. Molecular dynamics simulations suggested that desulfation reduced steric hindrance within the carbohydrate recognition domain of Galectin-3. In A549 cells, the compound at 10 μM reduced phosphorylated Smad and α-smooth muscle actin levels by 48.4% and 32.1%, respectively. In a bleomycin-induced mouse model of pulmonary fibrosis, the lead compound at 10 mg/kg reduced bronchoalveolar lavage fluid interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and transforming growth factor-β (TGF-β) concentrations by 60.3%, 73.5%, and 55.9%, respectively. Together, these findings link sulfation-pattern modification to enhanced Galectin-3 recognition and identify an fucosylated chondroitin sulfate derived trisaccharide as a preliminary antifibrotic lead that binds Galectin-3 and HMGB1 and attenuates fibrosis-associated responses in cellular and murine models. These results provide a basis for further investigation of the relationship between its protein-binding properties and antifibrotic activity.
    Keywords:  Fucosylated chondroitin sulfate; Galectin-3; High mobility group box 1; Oligosaccharide synthesis; Pulmonary fibrosis; Sulfation patterns
    DOI:  https://doi.org/10.1016/j.ejmech.2026.119474
  2. J Extracell Vesicles. 2026 Nov;pii: e70390. [Epub ahead of print]15(11):
      Extracellular vesicles (EVs) are lipid-enclosed particles produced by cells as a vehicle of intercellular communication and cargo exchange. Virus-infected cells produce EVs with altered cargo, which can include viral components. These EVs play functional roles in multiple aspects of viral infection. Their interactions with cells, including those occurring at the cellular surface prior to internalization, which are key to their subsequent functional effects, have not been studied extensively. In this work, we investigate the role of cellular glycosaminoglycans (GAGs)-major constituents of the extracellular matrix (ECM)-in cell binding by EVs produced by homeostatic cells and those infected with human cytomegalovirus (HCMV). We show that EVs from both HCMV-infected and uninfected cells interact with heparin, a highly sulfated form of heparan sulfate. However, in the context of binding to fibroblast cells, we show that heparan sulfate on both the cell and the EV surface inhibits EV-cell interactions, while promoting attachment by human cytomegalovirus. Instead of GAGs, EVs were found to interact with other ECM constituents, namely collagen and fibronectin, on the fibroblast surface. This work shows that heparan sulfate serves as a bi-directional negative regulator of fibroblast binding by EVs, while acting as a positive regulator of HCMV attachment. Thus, EVs and HCMV appear to utilize distinct, non-overlapping ECM ligands for cell binding, in both homeostasis and during HCMV infection.
    Keywords:  cell binding; cytomegalovirus; extracellular matrix; extracellular vesicles; glycosaminoglycan; heparan sulfate; virus
    DOI:  https://doi.org/10.1002/jev2.70390
  3. Retina. 2026 Nov 05.
       PURPOSE: Pentosan polysulfate sodium (PPS), a widely used treatment for interstitial cystitis, has been linked to a distinctive macular toxicity. A recent case report described a similar phenotype with fondaparinux, a related sulfated polysaccharide, raising the possibility of a broader class effect. We explored potential associations between exposure to non-PPS sulfated polysaccharides and retinal imaging findings resembling PPS maculopathy.
    METHODS: We conducted a single center retrospective study from 2018-2024. Emory Healthcare electronic health records were queried for adults with exposure to fondaparinux, enoxaparin, chondroitin containing products, alginate containing products, and/or dalteparin. Macular imaging during the study period was required for inclusion. A retina specialist reviewed macular imaging for features resembling PPS maculopathy. Given the high number of enoxaparin users with short exposure durations, imaging review for this group was limited to >1 year of documented exposure.
    RESULTS: A total of 218 patients were evaluated, including patients exposed to alginate (n = 12), fondaparinux (n = 25), chondroitin sulfate (n = 111), and enoxaparin (n = 70). Mean age at first qualifying macular imaging was 67.4 years and 59.5% were women. There were no cases resembling classic PPS maculopathy. Some patients did exhibit subtle macular pigment alterations without a clear diagnosis [fondaparinux 1 (4.0%); chondroitin sulfate 3 (2.7%); alginate 1 (8.3%)].
    CONCLUSIONS: This study did not identify a relationship between non-PPS sulfated polysaccharide exposure and the development of macular disease resembling classic PPS maculopathy. Larger studies with increased power may be warranted to determine whether a rare association may be present.
    Keywords:  Alginate; Chondroitin sulfate; Drug toxicity; Elmiron; Enoxaparin; Fondaparinux; Maculopathy; Pentosan polysulfate; Retinal toxicity; Sulfated polysaccharides
    DOI:  https://doi.org/10.1097/IAE.0000000000005047
  4. Front Bioeng Biotechnol. 2026 ;14 1930107
       Introduction: Perlecan, a heparan sulfate (HS) proteoglycan enriched in cell-derived decellularized extracellular matrix (dECM), carries N-terminal HS chains that act as co-receptor reservoirs for FGF-2, but whether this bioactivity is source-dependent is unknown.
    Methods: Passage-6 infrapatellar fat pad-derived stem cells (IPFSCs) were expanded on dECM from unmodified (dE) or SV40-immortalized (s-dE) IPFSCs, with or without heparinase III (HPA) to ablate HS chains, yielding five groups: PL (plastic), dE, dE(H), s-dE, and s-dE(H). Stemness, surface markers, and trilineage differentiation were assessed by RT-qPCR, histology, immunohistochemistry, and colorimetric assays over 21-day induction periods.
    Results: HPA selectively cleaved HS chains from matrix-resident perlecan without disrupting the core protein. Both dECM substrates suppressed adipogenic potential. HPA markedly enhanced adipogenesis in both groups. Chondrogenic and osteogenic responses were strikingly source-dependent: dE(H) preconditioning impaired chondrogenic differentiation, while s-dE(H) preconditioning conferred superior chondrogenic output-including the most prominent sGAG deposition and the largest pellet size among the groups examined-and exclusively promoted osteogenic matrix mineralization.
    Discussion: These findings indicate that perlecan-anchored HS chains are context-dependent regulators of stem cell fate, whose effects are modulated by dECM cellular origin, likely via structural differences in HS chains that differentially modulate FGF and BMP signaling. Targeted manipulation of matrix HS architecture offers a tunable strategy for dECM-based preconditioning in musculoskeletal regenerative medicine.
    Keywords:  decellularized extracellular matrix; heparan sulfate; heparinase III; infrapatellar fat pad-derived stem cells; mesenchymal differentiation; perlecan
    DOI:  https://doi.org/10.3389/fbioe.2026.1930107
  5. Food Chem. 2026 Oct 26. pii: S0308-8146(26)03948-8. [Epub ahead of print]532(Pt 4): 151788
      The global seafood-processing industry produces substantial quantities of underutilized marine byproducts, creating both environmental burdens and an urgent need for sustainable valorization strategies. Marine-derived polysaccharides possess unique structural motifs as functional food ingredients. Here, we report the scalable extraction, structural characterization, and functional evaluation of a novel fucosylated HS (VpHS) isolated from the pleopods of Volutharpa ampullacea perryi. Through optimized isolation processes and analysis, we demonstrate that VpHS features a highly sulfated heparin-like backbone (GlcNS/6S-GlcA2S). Crucially, one in nine disaccharide units bears a 4-O-sulfated α-L-fucose residue attached to the O-3 position of GlcA. VpHS exhibits substantially lower anticoagulant activity than heparin, enzymatic 6-O- and 3-O-sulfation led to a dramatic (>300%) enhancement in anticoagulant activity, suggesting a favorable safety profile for potential functional food applications. This study offers a sustainable route to valorize marine byproducts into value-added polysaccharides, and provides a structural and theoretical basis for the development of functional foods.
    Keywords:  Anticoagulant activity; Fucose; Functional foods; Heparin/heparan sulfate; Polysaccharides; Volutharpa ampullacea perryi
    DOI:  https://doi.org/10.1016/j.foodchem.2026.151788
  6. Pediatr Surg Int. 2026 Nov 03. pii: 7. [Epub ahead of print]43(1):
       PURPOSE: Heparan sulphate proteoglycans (HSPGs) regulate tumour cell interactions with the microenvironment. Sulfatase-2 (SULF2), an extracellular endosulfatase that modifies heparan sulphate (HS) 6-O-sulphation, has been implicated in neuroblastoma (NBL), particularly in high risk MYCN-amplified (MYCN-A) tumours. We investigated HS distribution in NBL and the effects of SULF2 knockdown on tumour cell behaviour.
    METHODS: HS expression was analysed in NBL cell lines using the anti HS antibody 10E4 and the phage display antibody HS3A8V. Cell migration was assessed following siRNA mediated SULF2 knockdown. HS expression in 65 primary human NBL specimens was quantified by colour deconvolution and compared by MYCN status and histological risk groups.
    RESULTS: HS epitopes were abundantly expressed on NBL cell surfaces, particularly in MYCN-A SK-N-BE(2) cells and localised along intercellular extensions. SULF2 knockdown significantly reduced cell migration, particularly in MYCN-A cells (p < 0.01), altered HS staining and reduced intercellular extensions. In primary MYCN-A tumours showed significantly greater 10E4 immunoreactivity than MYCN-non-amplified (NA) tumours with favourable or unfavourable histology (both p < 0.0001), with no difference between the latter groups.
    CONCLUSION: MYCN-A NBL demonstrates a distinct HS phenotype. SULF2-mediated HS remodelling may contribute to tumour cell migration and HS-rich intercellular extensions, identifying SULF2 as a potential therapeutic target in high-risk NBL.
    Keywords:  Heparan sulphate; MYCN amplification; Neuroblastoma; SULF2
    DOI:  https://doi.org/10.1007/s00383-026-06700-3
  7. ACS Omega. 2026 Nov 03. 11(43): 66016-66022
      When nanoparticles (NPs) enter biological environments, they rapidly acquire a layer of adsorbed proteins, known as the protein corona, which plays a central role in their interactions with cells. While extensive work has focused on how corona proteins interact with cell-surface receptors to modulate NP uptake, the role of corona-glycocalyx interactions has received comparatively little attention. In this Minireview, we highlight emerging evidence that heparin-binding proteins (HBPs) within the protein corona can engage glycosaminoglycans, such as heparan sulfate, in the cellular glycocalyx, thereby introducing an additional layer of molecular recognition at the cell surface. Drawing on recently published protein corona data sets, we further show that HBPs are frequently present and often abundant across protein coronas from diverse NP systems. These observations highlight HBPs as important, yet underappreciated, mediators of NP-cell interactions and uptake.
    DOI:  https://doi.org/10.1021/acsomega.6c09380
  8. Inflammopharmacology. 2026 Nov 05.
      Current therapies for asthma are limited by significant adverse effects, and many patients with severe asthma are still unable to achieve adequate symptom control, highlighting the need for novel therapeutic strategies. Fucosylated chondroitin sulfate (FucCS), a glycosaminoglycan isolated from the sea cucumber Holothuria grisea, demonstrates anti-inflammatory properties. This study investigated the therapeutic potential of FucCS in a murine model of ovalbumin (OVA)-induced allergic airway inflammation. C57BL/6 mice were sensitized and challenged with OVA and then treated intraperitoneally with FucCS (2 mg/kg), dexamethasone (DEXA, 2 mg/kg, positive control), or saline (SAL, vehicle control). Additional control mice received saline (CTRL/SAL) instead of OVA during both sensitization and challenge. Pulmonary function, the extent of peribronchial inflammation, total and differential cell counts in bronchoalveolar lavage fluid (BALF) and lung tissue, as well as levels of key inflammatory mediators were assessed. Compared to the OVA/SAL group, treatment with FucCS significantly reduced basal airway resistance, peribronchial inflammation, and polymorphonuclear cell infiltration in lung parenchyma. Furthermore, FucCS therapy attenuated BALF total cellularity and interleukin (IL)-4 levels and reduced IL-5 levels in lung homogenates, with effects comparable to dexamethasone. Neither treatment altered BALF eosinophil percentage. These findings demonstrate a limited, but significant anti-inflammatory effects of FucCS in experimental allergic inflammation and support its further development as a therapeutic candidate.
    Keywords:  anti-inflammatory therapy; asthma; eosinophil; glycoconjugates; marine drugs
    DOI:  https://doi.org/10.1007/s10787-026-02439-4
  9. Int J Anal Chem. 2026 ;2026 8276950
      Indoxyl sulfate (indican) is a tryptophan-derived metabolite generated by intestinal bacteria and subsequently excreted in urine. Urinary indican is considered an indicator of gut microbial imbalance and small-intestinal dysfunction because its production closely reflects the extent of microbial activity. In this study, we improved the classical indican color reaction-originally based on the Obermayer and Jaffé methods-by developing a simple colorimetric method using sodium hypochlorite pentahydrate (NaOCl·5H2O) as a novel oxidizing agent that is characterized by its high stability, strong reactivity, and ease of handling. By using this new oxidizing agent, the overall detection procedure becomes simpler to perform than the classical methods. The addition of hydrochloric acid followed by NaOCl·5H2O produced a blue pigment with an absorbance peak at approximately 600 nm, which was identified as indigo by electrospray ionization mass spectrometry. The method exhibited a visual detection limit of 6 mg/dL, comparable to that of the Obermayer and Jaffé methods. In the proposed method, a linear response between 6 and 12 mg/dL (R 2 = 0.9369) was obtained, and the recovery in spiked human urine samples was 69.3%; however, these results indicate that further improvement is required for reliable quantification of elevated indican levels. Moreover, the chromogenic reaction was susceptible to interference from ascorbic acid although partial suppression was achieved using ascorbate oxidase. Overall, this work provides a useful analytical approach for detecting elevated urinary indican levels in clinical and research settings, serving as an alternative to classical methods that rely on ferric chloride and calcium hypochlorite.
    Keywords:  ESI-MS; Jaffé method; Obermayer method; absorbance; indican; indigo; sodium hypochlorite pentahydrate (NaOCl·5H2O)
    DOI:  https://doi.org/10.1155/ianc/8276950
  10. Sci Transl Med. 2026 Nov 04. 18(874): eaeg0408
      Low-molecular weight heparin (LMWH) remains clinically indispensable for the prevention and treatment of thrombosis in cardiovascular surgery, hemodialysis, and other critical care settings. However, LMWH is constrained by heparin-induced thrombocytopenia (HIT) and supply chain vulnerabilities of animal-derived sources. This study used chemoenzymatic synthesis to engineer homogeneous dodecasaccharide 12G-2, decoupling anticoagulant efficacy from HIT risk via dual structural modulation. Substitution with 2-O-sulfated glucuronic acid conferred conformational rigidity, and engineered sulfation attenuated platelet factor 4 (PF4) binding, whereas the antithrombin-binding domain remained intact. 12G-2 exhibited nanomolar anti-Factor Xa (FXa) activity in vitro, enoxaparin-equivalent venous antithrombotic efficacy, and superior arterial antithrombotic activity in murine thrombosis models, and it showed diminished PF4 binding, attenuated pathological β sheet formation, and minimal recognition by HIT-related antibodies in vitro. Both in vitro and in a murine tail-bleeding model, 12G-2 demonstrated high protamine reversibility, exceeding standard LMWH enoxaparin neutralization efficiency. In washed human platelets, 12G-2-PF4 complexes with the HIT-mimicking antibody KKO failed to induce integrin αIIbβ3 activation or P-selectin release and elicited minimal platelet spreading comparable to resting controls. Safety assessments in mice showed no hepatotoxicity at tested doses and low immunogenicity in a murine PF4-heparin immunization model. In PF4-heparin antibody-positive mice, 12G-2 attenuated platelet activation while exerting stronger FXa inhibition than enoxaparin. These findings established 12G-2 as an alternative to LMWH.
    DOI:  https://doi.org/10.1126/scitranslmed.aeg0408
  11. Am J Physiol Endocrinol Metab. 2026 Nov 06.
      Oxysterols are oxygenated cholesterol derivatives with receptor-dependent and epigenetic activities. This review examines how mitochondrial cholesterol metabolism and oxysterol sulfation may connect lipid metabolism to DNA methylation and communication between hepatocytes and macrophages. Biochemical studies show that 25-hydroxycholesterol (25HC) and 27-hydroxycholesterol (27HC) activate DNA methyltransferase 1 (DNMT1), whereas their 3-sulfated derivatives inhibit the activities of DNMT1, DNMT3A, and DNMT3B. Cholestenoic acid (CA) has a concentration-dependent effect, activating DNMT1 at lower concentrations and inhibiting it at higher concentrations. In hepatocyte models, these activities are associated with altered promoter CpG methylation and expression of genes involved in lipid metabolism, inflammatory responses, and cell survival. The sulfated CA metabolite, 3β-sulfate-5-cholestenoic acid (3SCA), is secreted by hepatocytes and modifies inflammatory gene expression in macrophages. We propose an oxysterol epigenetic rheostat in which metabolite concentrations and sulfation influence DNMT activities. Published animal studies support protective effects of 25-hydroxycholesterol 3-sulfate in fatty liver disease, endotoxemia, and acetaminophen-induced liver injury. Its clinical formulation, larsucosterol, has shown favorable hepatic and metabolic signals in Phase 1b fatty liver studies and nominally significant mortality reductions in prespecified US Phase 2b alcohol-associated hepatitis (AH) analyses. These encouraging findings require confirmation because the overall Phase 2b primary endpoint was not met. Larsucosterol has received Fast Track and Breakthrough Therapy designations from the US Food and Drug Administration (FDA) for AH and is currently being evaluated in a registrational Phase 3 trial.
    Keywords:  Epigenetic regulation; Intercellular communication; Larsucosterol; Mitochondrial oxysterols; Oxysterol sulfation
    DOI:  https://doi.org/10.1152/ajpendo.90058.2026